Rekombinanter Blood Group Lewis Y Antikörper
Kurzübersicht für Rekombinanter Blood Group Lewis Y Antikörper (ABIN7864103)
Target
Antikörpertyp
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- Recombinant Lewis Y (Tumor Marker) Antibody
-
Spezifität
- This antibody recognizes a carbohydrate epitope present on tumor-associated Lewis Y antigen (Fucalpha1-2Galbeta1-4/3[Fucalpha1-3/4]GlcNAcbeta-). Lewis Y is expressed in large bowel tumors and colorectal carcinomas. It may be useful in the classification of human renal and bladder tumors. The Lewis Y antigen has been evaluated as a clinical marker for the diagnosis and prognosis of cholangiocarcinoma, hepatocellular carcinoma and breast cancer.
-
Aufreinigung
- 200ug/ml of Ab purified from Bioreactor Concentrate by Protein A/G.
-
Immunogen
- H3396 cultured line established from a metastasis of a human breast adenocarcinoma.
-
Isotyp
- IgG, kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 200 μg/mL
-
Buffer
- Prepared in 10 mM PBS with 0.05 % BSA & 0.05 % azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
-
Haltbarkeit
- 24 months
-
-
- Blood Group Lewis Y
-
Andere Bezeichnung
- Lewis Y
-
Hintergrund
-
Lewis Y antigen
bladder or hepatocellular carcinoma.|colon|Human lung
Target
-